Prof. Carole Bourquin
Prof. Carole Bourquin
Verified email at unige.ch
Title
Cited by
Cited by
Year
Sequence-specific potent induction of IFN-α by short interfering RNA in plasmacytoid dendritic cells through TLR7
V Hornung, M Guenthner-Biller, C Bourquin, A Ablasser, M Schlee, ...
Nature medicine 11 (3), 263-270, 2005
14972005
Omega-3 fatty acids prevent inflammation and metabolic disorder through inhibition of NLRP3 inflammasome activation
Y Yan, W Jiang, T Spinetti, A Tardivel, R Castillo, C Bourquin, G Guarda, ...
Immunity 38 (6), 1154-1163, 2013
4522013
5′-Triphosphate-siRNA: turning gene silencing and Rig-I activation against melanoma
H Poeck, R Besch, C Maihoefer, M Renn, D Tormo, SS Morskaya, ...
Nature medicine 14 (11), 1256-1263, 2008
3702008
Cellular immunostimulation by CpG-sequence-coated DNA origami structures
VJ Schuller, S Heidegger, N Sandholzer, PC Nickels, NA Suhartha, ...
ACS nano 5 (12), 9696-9702, 2011
3282011
CpG blocks immunosuppression by myeloid-derived suppressor cells in tumor-bearing mice
C Zoglmeier, H Bauer, D Nörenberg, G Wedekind, P Bittner, ...
Clinical Cancer Research 17 (7), 1765-1775, 2011
2142011
Myelin oligodendrocyte glycoprotein induces experimental autoimmune encephalomyelitis in the “resistant” Brown Norway rat: disease susceptibility is determined by MHC and MHC …
A Stefferl, U Brehm, M Storch, D Lambracht-Washington, C Bourquin, ...
The Journal of Immunology 163 (1), 40-49, 1999
1661999
Targeting CpG oligonucleotides to the lymph node by nanoparticles elicits efficient antitumoral immunity
C Bourquin, D Anz, K Zwiorek, AL Lanz, S Fuchs, S Weigel, ...
The Journal of Immunology 181 (5), 2990-2998, 2008
1412008
Delivery by cationic gelatin nanoparticles strongly increases the immunostimulatory effects of CpG oligonucleotides
K Zwiorek, C Bourquin, J Battiany, G Winter, S Endres, G Hartmann, ...
Pharmaceutical research 25 (3), 551-562, 2008
1362008
Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells
T Vollbrecht, R Stirner, A Tufman, J Roider, RM Huber, JR Bogner, ...
Aids 26 (12), F31-F37, 2012
1302012
Fc receptors are critical for autoimmune inflammatory damage to the central nervous system in experimental autoimmune encephalomyelitis
KB Abdul‐Majid, A Stefferl, C Bourquin, H Lassmann, C Linington, ...
Scandinavian journal of immunology 55 (1), 70-81, 2002
1102002
ISCOMATRIX adjuvant combines immune activation with antigen delivery to dendritic cells in vivo leading to effective cross-priming of CD8+ T cells
P Duewell, U Kisser, K Heckelsmiller, S Hoves, P Stoitzner, S Koernig, ...
The Journal of Immunology 187 (1), 55-63, 2011
1082011
Morphological and immunocytochemical characteristics indicate the yield of early progenitors and represent a quality control for human mesenchymal stem cell culturing
F Haasters, WC Prall, D Anz, C Bourquin, C Pautke, S Endres, ...
Journal of anatomy 214 (5), 759-767, 2009
1082009
Selection of molecular structure and delivery of RNA oligonucleotides to activate TLR7 versus TLR8 and to induce high amounts of IL-12p70 in primary human monocytes
A Ablasser, H Poeck, D Anz, M Berger, M Schlee, S Kim, C Bourquin, ...
The Journal of Immunology 182 (11), 6824-6833, 2009
912009
CD103 is a hallmark of tumor‐infiltrating regulatory T cells
D Anz, W Mueller, M Golic, WG Kunz, M Rapp, VH Koelzer, J Ellermeier, ...
International journal of cancer 129 (10), 2417-2426, 2011
792011
Immunostimulatory RNA blocks suppression by regulatory T cells
D Anz, VH Koelzer, S Moder, R Thaler, T Schwerd, K Lahl, T Sparwasser, ...
The journal of immunology 184 (2), 939-946, 2010
742010
Immunostimulatory RNA oligonucleotides trigger an antigen-specific cytotoxic T-cell and IgG2a response
C Bourquin, L Schmidt, V Hornung, C Wurzenberger, D Anz, ...
Blood 109 (7), 2953-2960, 2007
722007
Antigen delivery to plasmacytoid dendritic cells via BST2 induces protective T cell-mediated immunity
J Loschko, A Schlitzer, D Dudziak, I Drexler, N Sandholzer, C Bourquin, ...
The Journal of Immunology 186 (12), 6718-6725, 2011
712011
Systemic cancer therapy with a small molecule agonist of toll-like receptor 7 can be improved by circumventing TLR tolerance
C Bourquin, C Hotz, D Noerenberg, A Voelkl, S Heidegger, LC Roetzer, ...
Cancer research 71 (15), 5123-5133, 2011
682011
Immune response to functionalized mesoporous silica nanoparticles for targeted drug delivery
S Heidegger, D Gößl, A Schmidt, S Niedermayer, C Argyo, S Endres, ...
Nanoscale 8 (2), 938-948, 2016
642016
Immunotherapy with dendritic cells and CpG oligonucleotides can be combined with chemotherapy without loss of efficacy in a mouse model of colon cancer
C Bourquin, S Schreiber, S Beck, G Hartmann, S Endres
International journal of cancer 118 (11), 2790-2795, 2006
642006
The system can't perform the operation now. Try again later.
Articles 1–20